
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Stat5a CRISPR/Cas9 KO Plasmid (r) | sc-437303 | 20 µg | $397.00 |
STAT5A (signal transducer and activator of transcription 5A) is a latent cytoplasmic transcription factor activated downstream of JAK kinases in response to cytokines and growth factors, including prolactin, growth hormone, and interleukins. Upon phosphorylation, Stat5a dimerizes, translocates to the nucleus, and regulates gene programs controlling proliferation, differentiation, survival, and metabolic homeostasis in diverse tissues. In rat models, Stat5a signaling contributes to hematopoietic lineage regulation and endocrine-responsive transcriptional networks, making it relevant to studies of immune dysregulation, inflammation-linked phenotypes, and hormone-dependent remodeling. Perturbation of STAT5A activity is frequently used to interrogate JAK/STAT pathway wiring and transcriptional cross-talk with MAPK and PI3K signaling.
Stat5a CRISPR/Cas9 KO Plasmid (r) is a pool of plasmids designed for targeted disruption of the gene in rat cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Stat5a protein expression.
This CRISPR knockout system enables efficient generation of -deficient cell models for investigation of Stat5a signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.